Is Mesothelioma hereditary?

Mesothelioma is primarily considered an acquired, non-hereditary cancer caused by environmental or occupational exposure to asbestos, rather than an inherited genetic condition. While the vast majority of cases are not hereditary, a very small percentage of individuals may have a rare, inherited susceptibility to mesothelioma due to germline mutations in the BAP1 gene. In these rare familial cases, the condition follows an autosomal dominant inheritance pattern, meaning an affected parent has a 50% chance of passing the genetic predisposition to their child.

Is Mesothelioma a hereditary condition?

In the overwhelming majority of clinical cases, mesothelioma is not hereditary. It is classified as an acquired malignancy, meaning the DNA mutations that trigger the disease occur in somatic cells (body cells) during a person's lifetime, usually due to asbestos fiber inhalation or ingestion. Because these mutations are not present in the germline (sperm or egg cells), they cannot be passed down to children. However, researchers have identified a rare condition known as BAP1 Tumor Predisposition Syndrome. Families with this syndrome carry a germline mutation in the BAP1 gene, which significantly increases the lifetime risk of developing mesothelioma, uveal melanoma, and other cancers.

What is the role of genetics in Mesothelioma development?

While mesothelioma is generally not hereditary, genetic factors do play a role in how an individual's body responds to environmental exposures. Most people diagnosed with mesothelioma do not have a family history of the disease. In the rare instances where a hereditary component is suspected, the following factors are typically considered by clinical geneticists:

• Germline Mutations: Specifically, mutations in the BAP1 gene are the most well-documented genetic link to familial mesothelioma.


• Autosomal Dominant Pattern: If a family carries a pathogenic BAP1 mutation, it follows an autosomal dominant pattern, meaning only one copy of the mutated gene is needed to increase cancer risk.


• De Novo Mutations: Spontaneous (de novo) mutations in the BAP1 gene can occur, meaning an individual may be the first in their family to harbor the mutation, though this is rare.


• Multifactorial Risk: For the general population, the interaction between environmental asbestos exposure and individual genetic susceptibility remains a complex area of ongoing research.

When should genetic testing be considered?

Genetic testing for mesothelioma is not recommended for the general public or for every patient diagnosed with the disease. It is typically reserved for patients who meet specific clinical criteria, such as:

1. A personal history of multiple primary tumors (e.g., mesothelioma and uveal melanoma).


2. A strong family history of cancer, particularly if multiple relatives have been diagnosed with mesothelioma at a younger-than-average age.


3. Patients diagnosed with mesothelioma at a very young age without a clear history of heavy asbestos exposure.

Next steps

• Consult with an oncologist or a genetic counselor to review your family history if multiple relatives have been diagnosed with cancer.


• If you have a known history of asbestos exposure, prioritize regular screenings and follow-ups with a specialist physician.


• Connect with the mesothelioma community at DiseaseMaps.org to share experiences and find support from others navigating similar health journeys.


• Visit the NIH Genetic and Rare Diseases Information Center (GARD) website for updated information on BAP1 Tumor Predisposition Syndrome.

Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD) - BAP1 Tumor Predisposition Syndrome.


• Orphanet - Rare Cancer Information Portal.


• OMIM (Online Mendelian Inheritance in Man) - Entry #614327 (BAP1-related cancer susceptibility).


• Mesothelioma Applied Research Foundation - Genetic Research and Clinical Updates.